Cas:17696-60-5 N-(4-ethoxyphenyl)-1-[4-[(4-ethoxyphenyl)iminomethyl]phenyl]methanimine manufacturer & supplier

Chemical Name:N-(4-ethoxyphenyl)-1-[4-[(4-ethoxyphenyl)iminomethyl]phenyl]methanimine

CAS.NO:17696-60-5

Synonyms:Bisphenetidylterephthalaldehyde;Di-p-phenetidylterephthalaldehyde;N,N’-(1,4-PHENYLENEDIMETHYLIDYNE)DI-P-PHENETIDINE;TEREPHTHALBIS(P-PHENETIDINE)

Molecular Formula:C₂₄H₂₄N₂O₂

Molecular Weight:372.46000

HS Code:2922299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:550ºC at 760 mmHg

Density:1.05g/cm3

Index of Refraction:1.557

PSA:43.18000

Exact Mass:372.18400

LogP:5.98520

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Bisphenetidylterephthalaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TEREPHTHALBIS(P-PHENETIDINE) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TEREPHTHALBIS(P-PHENETIDINE) Use and application,N,N’-(1,4-PHENYLENEDIMETHYLIDYNE)DI-P-PHENETIDINE technical grade,usp/ep/jp grade.

Related News: He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. N-(4-ethoxyphenyl)-1-[4-[(4-ethoxyphenyl)iminomethyl]phenyl]methanimine manufacturer The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). N-(4-ethoxyphenyl)-1-[4-[(4-ethoxyphenyl)iminomethyl]phenyl]methanimine supplier From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. N-(4-ethoxyphenyl)-1-[4-[(4-ethoxyphenyl)iminomethyl]phenyl]methanimine vendor He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. N-(4-ethoxyphenyl)-1-[4-[(4-ethoxyphenyl)iminomethyl]phenyl]methanimine factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.